TY - JOUR
T1 - Long-Term Weight Outcome After Bariatric Surgery in Patients with Melanocortin-4 Receptor Gene Variants
T2 - a Case–Control Study of 105 Patients
AU - Cooiman, Mellody I.
AU - Alsters, Suzanne I. M.
AU - Duquesnoy, Maeva
AU - Hazebroek, Eric J.
AU - Meijers-Heijboer, Hanne J.
AU - Chahal, Harvinder
AU - le Beyec-le Bihan, Johanne
AU - Clément, Karine
AU - Soula, Hedi
AU - Blakemore, Alex I.
AU - Poitou, Christine
AU - van Haelst, Mieke M.
N1 - Funding Information: We would like to special thank S.M. Oussaada, MD, for her help in the conceptualization of this manuscript. Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Introduction: Pathogenic heterozygous MC4R variants are associated with hyperphagia and variable degrees of obesity. Several research groups have reported short-term weight loss outcomes after bariatric surgery in a few patients with MC4R variants, but lack of longer-term data prevents evidence-based clinical decision-making. Materials and Methods: Bariatric surgery patients with heterozygous (likely) pathogenic MC4R variants, from three collaborating centers in the Netherlands, France, and the UK, were compared to matched controls (matched 2:1 for age, sex, preoperative BMI, surgical procedure, and diabetes mellitus, but without MC4R mutations). Weight loss and regain outcomes up to 6 years of follow-up were compared. Results: At 60 months of follow-up after RYGB, cases with MC4R variants showed weight regain with a mean of 12.8% (± 10.4 SD) total weight loss (TWL) from nadir, compared to 7.9% (± 10.5 SD) in the controls (p = 0.062). Among patients receiving SG, the cases with MC4R variants experienced inferior weight loss (22.6% TWL) during the first year of follow-up compared to the controls (29.9% TWL) (p = 0.010). Conclusions: This multicenter study reveals inferior mid-term weight outcomes of cases with MC4R variants after SG, compared to RYGB. Since adequate weight loss outcomes were observed after RYGB, this procedure would appear to be an appropriate surgical approach for this group. However, the pattern of weight regain seen in cases with MC4R variants after both RYGB and SG highlights the need for pro-active lifelong management to prevent relapse, as well as careful expectation management. Graphical abstract: [Figure not available: see fulltext.].
AB - Introduction: Pathogenic heterozygous MC4R variants are associated with hyperphagia and variable degrees of obesity. Several research groups have reported short-term weight loss outcomes after bariatric surgery in a few patients with MC4R variants, but lack of longer-term data prevents evidence-based clinical decision-making. Materials and Methods: Bariatric surgery patients with heterozygous (likely) pathogenic MC4R variants, from three collaborating centers in the Netherlands, France, and the UK, were compared to matched controls (matched 2:1 for age, sex, preoperative BMI, surgical procedure, and diabetes mellitus, but without MC4R mutations). Weight loss and regain outcomes up to 6 years of follow-up were compared. Results: At 60 months of follow-up after RYGB, cases with MC4R variants showed weight regain with a mean of 12.8% (± 10.4 SD) total weight loss (TWL) from nadir, compared to 7.9% (± 10.5 SD) in the controls (p = 0.062). Among patients receiving SG, the cases with MC4R variants experienced inferior weight loss (22.6% TWL) during the first year of follow-up compared to the controls (29.9% TWL) (p = 0.010). Conclusions: This multicenter study reveals inferior mid-term weight outcomes of cases with MC4R variants after SG, compared to RYGB. Since adequate weight loss outcomes were observed after RYGB, this procedure would appear to be an appropriate surgical approach for this group. However, the pattern of weight regain seen in cases with MC4R variants after both RYGB and SG highlights the need for pro-active lifelong management to prevent relapse, as well as careful expectation management. Graphical abstract: [Figure not available: see fulltext.].
KW - Bariatric surgery
KW - MC4R variant
KW - Obesity
KW - Obesity genetics
UR - http://www.scopus.com/inward/record.url?scp=85122329375&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s11695-021-05869-x
DO - https://doi.org/10.1007/s11695-021-05869-x
M3 - Article
C2 - 34984630
SN - 0960-8923
VL - 32
SP - 837
EP - 844
JO - Obesity Surgery
JF - Obesity Surgery
IS - 3
ER -